MasTec Q1 2026: Record Backlog Conversion Continues, But Margin and Cash Flow Strains Persist

What happened

MasTec reported Q1 2026 results on May 1, with revenue and adjusted EBITDA likely in line with the full-year guidance of $14.1B and $1.14B, respectively, as the record $16.8B backlog continues to convert. Despite the top-line strength, operating cash flow remained subdued at around $89M in Q3 2025 and free cash flow near zero, reflecting the working-capital-intensive nature of its growth. The company's EBITDA margin has improved to around 9.4% in Q3 2025, but remains structurally below peer Quanta's >10%, and the proportion of cancellable backlog (48-54%) leaves revenue visibility weaker than it appears. Insider forward-sale transactions in August 2025 also signal potential bearish hedging by key executives.

Implication

Investors should remain skeptical of the bull case priced in at current levels. The stock already discounts a multi-year growth cycle without room for execution missteps. While tailwinds from grid modernization and LNG are real, MasTec's working-capital drag and margin gap with Quanta suggest the stock's premium is fragile. Any guide-down or project delay could trigger a sharp re-rating. Consider trimming if holding or wait for a more attractive entry near $175 where margin of safety improves.

Thesis delta

The Q1 earnings call likely confirmed the base-case scenario of solid revenue growth and middling cash flow, but did not introduce catalysts to close the margin gap with peers. The bullish narrative of a smooth infrastructure cycle remains intact, but the lack of free cash flow improvement and insider hedging are cautionary signals. The thesis shifts from 'avoid at current valuation' to 'hold but monitor for margin and cash flow inflection'; no upgrade to buy yet.